<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384056</url>
  </required_header>
  <id_info>
    <org_study_id>AR-1974</org_study_id>
    <nct_id>NCT03384056</nct_id>
  </id_info>
  <brief_title>Respiration and The Airway With Supraglottic Airway Devices</brief_title>
  <official_title>Comparison of Air-Q Self Pressurized Airway Device With Blocker With Proseal Laryngeal Mask Airway in Anesthetized Paralyzed Adult Female Patients Undergoing Elective Gynecological Operations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reham Ali Abdelhaleem Abdelrahman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to compare the airway seal pressure( oropharyngeal leak pressure) of&#xD;
      the Self Pressurized Airway Device with Blocker® with the ProsealTM Laryngeal Mask Airway&#xD;
      (P-LMA)in anesthetized paralyzed adult female patients undergoing elective gynecological&#xD;
      operations. The investigators aim at assessment of fitting of both devices against the&#xD;
      glottic region that detected by the flexible fiberoptic bronchoscope( Pentex Corporation,&#xD;
      Medical Division, Singapore)and assessment of any associated postoperative complications.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      The investigators hypothesize that the self-pressurized air-Q with blocker has a greater seal&#xD;
      pressure compared to Proseal, easier and faster in insertion with less morbidity and&#xD;
      complications during and after its insertion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be carried on adult female patients to reduce variability in size of the&#xD;
      chosen device to enable the investigators to analyze the performance parameters of the two&#xD;
      devices with greater authority. The study will be done on anesthetized paralyzed adult female&#xD;
      patients undergoing elective gynecological operations that require neuromuscular block but&#xD;
      not necessarily tracheal intubation. The investigators will recruit 150 adult female(18-55&#xD;
      years old, ASAI&amp;II) patients to a prospective randomized comparative controlled two-arm&#xD;
      parallel clinical trial. Patients with history of upper respiratory tract infections,&#xD;
      obstructive sleep apnea, potentially full stomach (trauma, morbid obesity BMI&gt; 35, pregnancy,&#xD;
      history of gastric regurgitation and heart burn), those with esophageal reflux (hiatus&#xD;
      hernia), and those of coagulation disorders will be excluded from the study. All patients&#xD;
      will be assessed pre-operatively El-Ganzouri airway score to assess the expected difficulty&#xD;
      of intubation and patients with airway scores ≥ 5 will be excluded from the study. The&#xD;
      patients will be randomly allocated into two groups(the SP-Blocker group &amp; the P-LMA group;&#xD;
      each group is 75 patients) using computer generated program . An online randomization program&#xD;
      (http://www.randomizer.org) will be used to generate random list and to allocate patients&#xD;
      into the study groups. Random allocation numbers will be concealed in opaque closed envelops.&#xD;
      The patient and investigator assessing study outcomes will all be blinded to the study groups&#xD;
      allocation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">November 1, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>airway seal pressure</measure>
    <time_frame>one year</time_frame>
    <description>pressure at which leak starts to occur</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fitting of the device against larynx</measure>
    <time_frame>one year</time_frame>
    <description>detected by the flexible fiberoptic</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>insertion time of the device</measure>
    <time_frame>one year</time_frame>
    <description>is defined as time in seconds from the chosen device touching the teeth to the first recorded near rectangular capnogram curve in the presence of satisfactory bilateral chest expansion.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Laryngeal Masks Comparison</condition>
  <arm_group>
    <arm_group_label>Self Pressurized Airway Device with Blocker</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Proseal Laryngeal Mask Airway</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Self Pressurized Airway Device with Blocker</intervention_name>
    <description>used in adult low risk females undergoing elective gynecological operations</description>
    <arm_group_label>Self Pressurized Airway Device with Blocker</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Proseal Laryngeal Mask Airway</intervention_name>
    <description>used in adult low risk females undergoing elective gynecological operations.</description>
    <arm_group_label>Proseal Laryngeal Mask Airway</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult female patients undergoing elective gynecological operations.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult female patients ASA I&amp;II&#xD;
&#xD;
          -  Age: 18- 55 years old&#xD;
&#xD;
          -  BMI &lt; 35&#xD;
&#xD;
          -  Undergoing elective gynecological operations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of upper respiratory tract infections and obstructive sleep&#xD;
             apnea.&#xD;
&#xD;
          -  Patients who are potentially full stomach such as trauma, pregnancy, history of&#xD;
             gastric regurgitation &amp;heart burn, those with esophageal reflux or hiatus hernia.&#xD;
&#xD;
          -  Patients with coagulation disorders.&#xD;
&#xD;
          -  Patients with El-Ganzouri airway score ≥ 5 will.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesia, Surgical ICU, and Pain Management</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 14, 2017</study_first_submitted>
  <study_first_submitted_qc>December 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2017</study_first_posted>
  <last_update_submitted>August 21, 2021</last_update_submitted>
  <last_update_submitted_qc>August 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Reham Ali Abdelhaleem Abdelrahman</investigator_full_name>
    <investigator_title>Anaesthesia Lecturer</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

